Warren Buffett’s Berkshire Hathaway reported a 4% year-on-year decline in second-quarter operating profit on Saturday, ...

Axon Enterprise, Inc. (NASDAQ: AXON) ranks among the best growth stocks to buy for the next 10 years. Ahead of the company’s ...

Just because a stock is a Dividend Champion doesn't mean it's an overall winner. However, some members of the group could be attractive to investors. Here are three Dividend Champion stocks I'm ...

CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced ...

Regeneron reports strong Q2 2025 growth with Dupixent sales up 21% and EYLEA HD hitting record highs. Explore key earnings insights and pipeline updates.

In its first commercial quarter for ATTR-cardiomyopathy, Alnylam’s Amvuttra reached roughly 1,400 patients and made more than ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, ...

Apple has reported record revenues and done so with success in three key areas, none of which required Apple Intelligence, which analysts insisted the company needed to concentrate on. Here's how the ...

Tweet; Print; Track Keywords; Bailey McCann, Opalesque New York: US oil and gas producers are facing a number of headwinds. OPEC announced last week it would release more supply o ...

During that time, revenues at C.H. Robinson and in NAST were largely flat, owing to still-weak freight markets. That is the definition of productivity increases: getting done the same amount of work ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, ...

Wall Street isn't happy with Apple's slow AI progress, but one analyst says investors need a bit more patience. TD Cowen's Krish Sankar recently wrote that he thinks Apple deserves a bit of time to ...